Soleus Private Equity Fund I, L.P.'s Net Worth

-$1.72 Million

Estimate Recalculated Jul 1, 2024 07:41PM EST

Who is Soleus Private Equity Fund I, L.P.?

Soleus Private Equity Fund I, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Lyra Therapeutics, Inc., and BioAtla, Inc..

SEC CIK

Soleus Private Equity Fund I, L.P.'s CIK is 0001752427

Past Insider Trading and Trends

2020 was Soleus Private Equity Fund I, L.P.'s most active year for acquiring shares with 4 total transactions. Soleus Private Equity Fund I, L.P.'s most active month to acquire stocks was the month of April. 2020 was Soleus Private Equity Fund I, L.P.'s most active year for disposing of shares, totalling 4 transactions. Soleus Private Equity Fund I, L.P.'s most active month to dispose stocks was the month of April. 2020 saw Soleus Private Equity Fund I, L.P. paying a total of $2,750,826.66 for 629,320 shares, this is the most they've acquired in one year. In 2020 Soleus Private Equity Fund I, L.P. cashed out on 15,322,181 shares for a total of $270,544.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Lyra Therapeutics, Inc. (LYRA) Snapshot price: $4.905

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+181.00%
612.41K
$14.16
$2,480,282.66
950.75K
May 5
Form 3
—
0
—
—
0
No matching records found

BioAtla, Inc. (BCAB) Snapshot price: $2.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found